| Literature DB >> 17149879 |
Gabriele Murineddu1, Paolo Lazzari, Stefania Ruiu, Angela Sanna, Giovanni Loriga, Ilaria Manca, Matteo Falzoi, Christian Dessì, Maria M Curzu, Giorgio Chelucci, Luca Pani, Gérard A Pinna.
Abstract
New analogues (2a-p) of the previously reported CB(2) ligands 6-methyl- and 6-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB(2) receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17149879 DOI: 10.1021/jm060920d
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446